SK608989A3 - The composition for transdermal application with gestodene content - Google Patents
The composition for transdermal application with gestodene content Download PDFInfo
- Publication number
- SK608989A3 SK608989A3 SK608989A SK608989A SK608989A3 SK 608989 A3 SK608989 A3 SK 608989A3 SK 608989 A SK608989 A SK 608989A SK 608989 A SK608989 A SK 608989A SK 608989 A3 SK608989 A3 SK 608989A3
- Authority
- SK
- Slovakia
- Prior art keywords
- layer
- gestodene
- composition
- skin
- optionally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19893910578 DE3910578A1 (de) | 1989-03-29 | 1989-03-29 | Mittel zur transdermalen applikation enthaltend gestoden |
Publications (2)
Publication Number | Publication Date |
---|---|
SK278438B6 SK278438B6 (en) | 1997-05-07 |
SK608989A3 true SK608989A3 (en) | 1997-05-07 |
Family
ID=6377622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK608989A SK608989A3 (en) | 1989-03-29 | 1989-10-27 | The composition for transdermal application with gestodene content |
Country Status (5)
Country | Link |
---|---|
CZ (1) | CZ277870B6 (pl) |
DE (1) | DE3910578A1 (pl) |
PL (2) | PL162410B1 (pl) |
RU (1) | RU2044541C1 (pl) |
SK (1) | SK608989A3 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2131822C (en) * | 1992-03-21 | 2002-12-17 | Walter Elger | Use of estriol for treating climacteric osteoporosis |
DE19526864A1 (de) * | 1995-07-22 | 1997-01-23 | Labtec Gmbh | Hormonpflaster |
PT1191927E (pt) | 1999-07-02 | 2003-07-31 | Lohmann Therapie Syst Lts | Sistema de microrreservatorios a base de polissiloxanos e solventes ambifilicos |
DE10019171A1 (de) * | 2000-04-07 | 2001-10-18 | Schering Ag | Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe |
WO2008136699A1 (fr) * | 2007-05-04 | 2008-11-13 | Igor Alexandrovich Bazikov | Patch transdermique à microcapsules et procédé de fabrication correspondant |
-
1989
- 1989-03-29 DE DE19893910578 patent/DE3910578A1/de not_active Withdrawn
- 1989-10-26 PL PL28752689A patent/PL162410B1/pl unknown
- 1989-10-26 PL PL28203389A patent/PL162400B1/pl unknown
- 1989-10-27 CZ CS896089A patent/CZ277870B6/cs not_active IP Right Cessation
- 1989-10-27 SK SK608989A patent/SK608989A3/sk unknown
-
1990
- 1990-06-26 RU SU904830921A patent/RU2044541C1/ru active
Also Published As
Publication number | Publication date |
---|---|
PL162400B1 (pl) | 1993-11-30 |
SK278438B6 (en) | 1997-05-07 |
PL287526A1 (en) | 1991-10-21 |
PL282033A1 (en) | 1991-03-11 |
CZ277870B6 (en) | 1993-06-16 |
PL162410B1 (pl) | 1993-11-30 |
DE3910578A1 (de) | 1990-10-04 |
CZ608989A3 (en) | 1993-02-17 |
RU2044541C1 (ru) | 1995-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3238389B2 (ja) | ゲストデン含有の経皮適用のための薬剤 | |
RU2154455C2 (ru) | Чрескожные терапевтические системы, содержащие половые стероиды | |
AU687013B2 (en) | Transdermal application agent containing 3-keto-desogestrel | |
US5858394A (en) | Agent for transdermal administration that contains gestodene esters | |
DD286293A5 (de) | Mittel zur transdermalen applikation enthaltend gestoden | |
SK608989A3 (en) | The composition for transdermal application with gestodene content | |
JPH09508911A (ja) | デソゲストレルを含有する経皮適用剤 | |
JPH11509222A (ja) | 13−エチル−17β−ヒドロキシ−11−メチレン−18,19−ジノル−17α−プレグン−4−エン−20−イン−3−オンのエステルを含む経皮投与のための剤 | |
JPH04505333A (ja) | ロリプラムを含有する皮膚浸透移行性適用剤 | |
JPH09510697A (ja) | 14α,17α−エタノエストラ−1,3,5(10)−トリエン−3,17β−ジオールを含有する経皮投与のための薬剤 | |
HUT74616A (en) | Agent, intended for transdermal administration, containing 14alfa, 17alfa-ethanoestra-1,3,5(10)-triene-3,17beta-diol | |
CA2182188A1 (en) | Agent, intended for transdermal administration, containing 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol |